This text is a result of machine translation.
Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum
A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.
May 18, 2026 02:22 PM
Insilico Medicine (英矽智能) Signs Strategic Drug Discovery Partnership with Takeda (武田制药), Deal Worth Up to US$600 Million
Chinese AI drug discovery company Insilico Medicine (英矽智能) has signed a global strategic collaboration with Japanese pharmaceutical company Takeda (武田制药), with the total potential deal value reaching up to US$600 million. Announced in early July, the agreement marks another milestone in the international commercialization of China's AI-powered drug discovery technologies through collaboration with a leading multinational pharmaceutical company.
Jul 16, 2026 02:33 PM
Sunshine City responded to the rumor that the interest extension plan was approved: the news is true
The trading amount of well-off shares was nearly 1.5 billion
Xiaokang Co., Ltd.: mass delivery will begin in March. The follow-up models of M5 will have Huawei high-level automatic driving
A Small Aircraft, a Bigger Bet: How China's Worthy Aero Plans to Scale Up
Jul 28, 2026 03:24 PM
EqualOcean Releases 2026 Chinese GoGlobal Physical Retail Brands Top 10 at GGF2026
Jun 17, 2026 02:50 PM